AZD0186 / AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD0186 / AstraZeneca
NCT05694741: A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

Terminated
1
31
US
AZD0186, Placebo
AstraZeneca, Parexel
Type 2 Diabetes
05/23
05/23

Download Options